vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 06, 2025 Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026 $80 million private placement strengthens balance sheet and supports Phase 3 CATT1 completion Announced issuance of new U.S. patent covering crystalline salts and co-crystals […]

Mueller Water Products Reports Record Fourth Quarter and Full Year 2025 Results; Introduces Fiscal 2026 Guidance

Mueller Water Products Reports Record Fourth Quarter and Full Year 2025 Results; Introduces Fiscal 2026 Guidance GlobeNewswire November 06, 2025 Increased Net Sales 9.4% in Quarter, 8.7% in Fiscal Year Earned Net Income per Diluted Share of $0.33 in Quarter, $1.22 in Fiscal Year Reported Adjusted Net Income per Diluted Share of $0.38 in Quarter,

Prospect Capital Announces Financial Results for September 2025

Prospect Capital Announces Financial Results for September 2025 GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended September 30, 2025. FINANCIAL RESULTS All amounts in $000's exceptper share amounts (on weighted averagebasis for period

Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update

Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 06, 2025 – CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer – – Q3 2025 ending cash, cash equivalents and marketable securities of $191.7 million – – LOQTORZI(R) net revenue was $11.2 million, a 12% increase

SEIU HEALTHCARE ACHIEVES LANDMARK ARBITRATION WIN FOR ONTARIO LONG-TERM CARE

Union-powered WorkersFirst platform ready for adoption by residences as part of transformative approach to healthcare workforce challenges SEIU Healthcare's commitment to building better healthcare solutions for Ontario has achieved a landmark arbitration victory, with Ontario long-term care operators now mandated to sign service agreements for the WorkersFirst digital platform, powered by SEIU Healthcare, to address

Kingsway Reports Third Quarter 2025 Financial Results

— Revenue Growth of 37% to $37.2 Million — — KSX Revenue Growth of 104% to $19.0 Million — — Extended Warranty Revenue Growth of 2% to $18.2 Million; Extended Warranty Cash Sales up 14% — — KSX Represents a Majority of Revenue for First Time — Management to Host Conference Call Today, November 6,

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results

(NASDAQ:OXBR),(NASDAQ:OXBRW), GRAND CAYMAN, Cayman Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the three and nine months ended September 30, 2025. SurancePlus 2025-2026 Tokenized Reinsurance Update SurancePlus

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results GlobeNewswire November 06, 2025 GRAND CAYMAN, Cayman Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON),one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care – all without relying on prior authorization. The national partnership seeks to

Saul Centers, Inc. Reports Third Quarter 2025 Earnings

Saul Centers, Inc. (NYSE: BFS) (the “Company”), an equity real estate investment trust (“REIT”), announced operating results for the quarter ended September 30, 2025 (“2025 Quarter”). Total revenue for the 2025 Quarter increased to $72.0 million from $67.3 million for the quarter ended September 30, 2024 (“2024 Quarter”). Net income decreased to $14.0 million for

Scroll to Top